European Union: Patentability Of Methods Of Treatment And Diagnosis

Last Updated: 15 May 2019
Article by Reuben Friend

The European Patent Office's (EPO's) approach to the patentability of inventions in the medical field is based on the principle that medical practitioners should not be restricted at the point of care of a patient by the concern that a treatment or diagnostic method might be covered by a patent.

This has led to the provision of Article 53(c) of the European Patent Convention (EPC), which specifies that:

"European patents shall not be granted in respect of ... methods for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body..."

It may appear that Article 53(c) EPC significantly prohibits the patenting of inventions in the medical field in Europe. However, as discussed below, with careful wording, it is still possible to validly patent many inventions in the medical field.  

Method of Treatment

Whilst methods of treatment are not patentable in Europe, it is possible to validly patent the use of a substance or composition for surgery, therapy or diagnosis under the provision of Article 53(c) EPC second clause, which states that:

"...this provision shall not apply to products, in particular substances or compositions, for use of these methods."

This enables the use of a purpose-limited use claim to circumvent the exclusion of methods from patentability provided by Article 53(c) EPC.

If the substance or composition is known per se, but has not previously been used in a medical method, it is still possible to obtain broad protection for the use in any medical method using a so-called "first medical use" claim of the format "[Substance/composition] X for use in [therapy/in vivo diagnosis/surgery]" (Article 54(4) EPC), even if only one therapeutic use has been described in the patent. Thus, novelty and inventiveness is defined by the use of the substance or composition in a medical method, and not the substance or composition per se.  

In addition, even if a medical use for any given substance or composition is already known, it is possible to protect a different medical use of that substance or composition using a claim in the format "[Substance/composition] X for use in [treating/ in vivo diagnosis of] Y]" (Article 54(5) EPC). In such claims, novelty can arise from the new disease that is treated. Of course, the Applicant must then show that treatment of the new disease would not have been obvious in order to demonstrate an inventive step.

A medical use claim can also be directed to specific uses of known substances or compositions for the new treatment of the same disease, and novelty and inventive step established by reciting new and inventive routes of administration (T51/93) and novel sub-groups of patients (T19/86).

Many medical methods involve the use of a medical device or apparatus. The use of first and second medical use claims is restricted to methods in which the medical effect is based on a substance or composition. Therefore, it is not possible to protect the use of a medical device or apparatus by a first or second medical use claim, as this is not regarded as a substance or composition within the meaning of Article 53(c) EPC. However, such medical devices can be protected by a claim drawn to the device per se, which will protect the device regardless of its use.

Surgery or Therapy

To be excluded as a method of treatment under Article 53(c) EPC, the treatment must be by surgery or therapy. If the treatment does not relate to either of these, then it will not be captured by the Article 53(c) EPC exclusion, and would therefore be patent-eligible.

Therapy relates to the curing, prevention or alleviation of a disorder or malfunction of the body, i.e. bringing a body back to its healthy state (T224/91). Thus, purely cosmetic treatments would not be classed as a therapy, as long as any cosmetic effect was not inextricably linked to a corresponding therapeutic effect.

Treatment by surgery relates to the nature of the treatment rather that its intended purpose. "Surgery" is defined as a physical intervention on the body, and methods that involve an invasive intervention are excluded from patentability as a method of treatment by surgery. The EPO Enlarged Board of Appeal has indicated that invasive methods comprise a substantial physical intervention on the body, which requires professional medical expertise to be carried out and which entails a substantial health risk even when carried out with the required professional care and expertise (G 1/07). Such methods may include injection, endoscopy, or excision amongst others. If a surgical step is not essential to the invention, we would recommend drafting the claims such that it is made clear that such a step precedes the claimed method. This can be achieved by use of expressions such as "pre-delivered", "pre-implanted" or "pre-inserted", and so on.

Diagnostic Methods

Methods of diagnosis are also excluded from patentability at the EPO. However, this exclusion has been interpreted narrowly by the EPO Enlarged Board of Appeal in its decision of G1/04, which sets out the conditions that must be met for a method to constitute a diagnostic method.

The claim must include method steps relating to all of the following phases:

(i) the examination phase, involving the collection of data,

(ii) the comparison of these data with standard values,

(iii) the finding of any significant deviation, i.e. a symptom, during the comparison,

(iv) the attribution of the deviation to a particular clinical picture, i.e. the deductive medical or veterinary decision phase (diagnosis for curative purposes stricto sensu).

Thus, to be excluded from patentability, a diagnostic method must include all of the necessary steps to obtain and analyse data, and come to a diagnostic conclusion. If any one of these steps is missing, the method will not be regarded as a diagnostic method embraced by the exclusion of Article 53(c) EPC. However, if all of these steps are seen as essential to the method, it would not be possible to simply delete one of these steps to circumvent this exclusion. Therefore, we would always recommend providing teaching in a patent application that highlights that one or more of these steps is not essential to the performance of the method, if possible.

Prognostic Methods are Patentable

Methods that do not lead to the diagnosis of a clinical picture are not excluded from patentability. For example, methods of data collection based on step (i) are patentable. Similarly, a method of data collection or analysis that does not enable a decision to be made on the treatment necessary (i.e. step (iv) above) will also be patentable, and we have had success for our clients arguing that methods of prognosis do not fall within the provision of Article 53(c) EPC, as they do not result in a diagnosis in the strictest sense of Article 53(c) EPC, in that the method of prognosis can be defined as predicting the rate of progression or improvement and/or the duration of a condition that has already been diagnosed.  

Practised on the Human Body

In addition to the above steps, the exclusions only extend to treatments and diagnosis practised directly on the human or animal body.

Therefore, if a technical step of a claimed method is carried out in the absence of the body, the method should not be considered a diagnostic method excluded from patentability.

Thus, it is possible to protect the indirect (i.e. in vitro, ex vivo) treatment of a condition, or a diagnostic method, that is performed on body tissues or fluids after they have been removed from the human or animal body. Examples of the types of methods that would be patent-eligible include performing a diagnostic test on a blood sample or a treatment on an organ tissue before transplantation. However, treatment of blood by dialysis where the blood is returned to the patient would be excluded from patentability, as the patient would have to be present during the treatment.

In practice, we would recommend including at least one technical in vitro step and omitting any non-essential steps that are practised on the human body. For example, in a method that comprises a method of diagnosis based on identifying a particular biomarker in a blood sample, the step of actually obtaining the sample from a patient should be omitted from the claimed method, and the method may instead recite preforming the method "on a sample obtained from a subject".


Methods of treatment by surgery or therapy and diagnostic methods practised on the human or animal body are excluded from patent protection at the EPO, and this may appear to significantly prohibit the ability of applicants to obtain patent protection in the medical field in Europe. However, by identifying the core aspects of an invention, and with careful claim drafting, it is often possible to circumvent these exclusions and protect many aspects of medical-related inventions.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions